Cowen Starts Simcere Pharmaceutical (SCR) at Neutral
Tweet
Share
E-mailGet Alerts SCR Hot Sheet
Price: $35.58 --0%
Rating Summary:
2 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Rating Summary:
2 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Join SI Premium – FREE
Cowen initiates coverage on Simcere Pharmaceutical (NYSE: SCR) with a Neutral.
For an analyst ratings summary and ratings history on Simcere Pharmaceutical click here. For more ratings news on Simcere Pharmaceutical click here.
Shares of Simcere Pharmaceutical closed at $8.65 yesterday.
For an analyst ratings summary and ratings history on Simcere Pharmaceutical click here. For more ratings news on Simcere Pharmaceutical click here.
Shares of Simcere Pharmaceutical closed at $8.65 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA Securities Starts Kanzhun Ltd. (BZ) at Neutral
- BofA Securities Starts Definium Therapeutics Inc (DFTX) at Buy
- argenx SE (ARGX) PT Raised to $1,353 at TD Cowen
Create E-mail Alert Related Categories
New CoverageRelated Entities
Cowen & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
